Distinguished in Limb-Girdle Muscular Dystrophy Type 2C

Dr. Benjamin R. Brooks

Neurology
1010 Edgehill Rd N, 
Charlotte, NC 
Distinguished in Limb-Girdle Muscular Dystrophy Type 2C
1010 Edgehill Rd N, 
Charlotte, NC 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Benjamin Brooks is a Neurologist in Charlotte, North Carolina. Dr. Brooks is rated as a Distinguished provider by MediFind in the treatment of Limb-Girdle Muscular Dystrophy Type 2C. His top areas of expertise are Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), Primary Lateral Sclerosis, Spinal Muscular Atrophy (SMA), Spinal and Bulbar Muscular Atrophy, and Gastrostomy.

His clinical research consists of co-authoring 55 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Neurology
Licenses
Internal Medicine in NC
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO

Locations

1010 Edgehill Rd N, Charlotte, NC 28207

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

Expanded Access Protocol (EAP) of Idebenone in Patients With Duchenne Muscular Dystrophy
Expanded Access Protocol (EAP) of Idebenone in Patients With Duchenne Muscular Dystrophy
Enrollment Status: No_longer_available
Publish Date: April 21, 2023
Intervention Type: Drug
Establishment of a Tissue Bank (Blood, CSF) for the Understanding of the Disease Progression and Early Diagnosis of Motor Neuron Disease (MND).
Establishment of a Tissue Bank (Blood, CSF) for the Understanding of the Disease Progression and Early Diagnosis of Motor Neuron Disease (MND).
Enrollment Status: Terminated
Publish Date: July 11, 2022
Establishment of Phenotypic Profiles of Muscular Dystrophies for Understanding Disease Progression, Diagnosis and Development of New Therapies
Establishment of Phenotypic Profiles of Muscular Dystrophies for Understanding Disease Progression, Diagnosis and Development of New Therapies
Enrollment Status: Completed
Publish Date: April 26, 2022
A Phase III Double-blind, Randomized, Placebo-Controlled Study Assessing the Efficacy, Safety and Tolerability of Idebenone in Patients With Duchenne Muscular Dystrophy Receiving Glucocorticoid Steroids
A Phase III Double-blind, Randomized, Placebo-Controlled Study Assessing the Efficacy, Safety and Tolerability of Idebenone in Patients With Duchenne Muscular Dystrophy Receiving Glucocorticoid Steroids
Enrollment Status: Terminated
Publish Date: December 03, 2021
Intervention Type: Drug
Study Drug: Idebenone
Study Phase: Phase 3
A Phase III Open-Label Extension Study to Assess the Long-Term Safety and Efficacy of Idebenone in Patients With Duchenne Muscular Dystrophy (DMD) Who Completed the SIDEROS Study
A Phase III Open-Label Extension Study to Assess the Long-Term Safety and Efficacy of Idebenone in Patients With Duchenne Muscular Dystrophy (DMD) Who Completed the SIDEROS Study
Enrollment Status: Terminated
Publish Date: December 03, 2021
Intervention Type: Drug
Study Drug: Idebenone
Study Phase: Phase 3
A Phase 2 Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of NP001 in Subjects With Amyotrophic Lateral Sclerosis (ALS) and Evidence of Elevated Systemic Inflammation
A Phase 2 Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of NP001 in Subjects With Amyotrophic Lateral Sclerosis (ALS) and Evidence of Elevated Systemic Inflammation
Enrollment Status: Completed
Publish Date: May 07, 2018
Intervention Type: Drug
Study Phase: Phase 2
View 5 Less Clinical Trials

55 Total Publications

Efficacy of Radicava® IV (intravenous edaravone) in subjects with differing trajectories of disease progression in amyotrophic lateral sclerosis: Use of a novel statistical approach for post hoc analysis of a pivotal phase 3 clinical trial.
Efficacy of Radicava® IV (intravenous edaravone) in subjects with differing trajectories of disease progression in amyotrophic lateral sclerosis: Use of a novel statistical approach for post hoc analysis of a pivotal phase 3 clinical trial.
Journal: Journal of the neurological sciences
Published: May 27, 2024
Similar Doctors
Leo F. Mccluskey
Experienced in Limb-Girdle Muscular Dystrophy Type 2C
Dr. Leo F. Mccluskey
Neurology | Neuromusculoskeletal Medicine
Experienced in Limb-Girdle Muscular Dystrophy Type 2C
Dr. Leo F. Mccluskey
Neurology | Neuromusculoskeletal Medicine

Atrium Health Neurology Specialty Care, A Facility Of Carolinas Medical Center

1010 Edgehill Road N., 
Charlotte, NC 
 (0.8 miles away)
704-468-0101
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Leo Mccluskey is a Neurologist and a Neuromusculoskeletal Medicine provider in Charlotte, North Carolina. Dr. Mccluskey is rated as a Distinguished provider by MediFind in the treatment of Limb-Girdle Muscular Dystrophy Type 2C. His top areas of expertise are Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), Primary Lateral Sclerosis, Spinal Muscular Atrophy (SMA), and Spinal and Bulbar Muscular Atrophy. Dr. Mccluskey is currently accepting new patients.

Andrew F. Gross
Experienced in Limb-Girdle Muscular Dystrophy Type 2C
Dr. Andrew F. Gross
Neurology | Neurosurgery
Experienced in Limb-Girdle Muscular Dystrophy Type 2C
Dr. Andrew F. Gross
Neurology | Neurosurgery

Duke Health Neurology/Neuro-Ophthalmology Mooresville

131 Medical Park Rd, 
Mooresville, NC 
 (24.2 miles away)
Experience:
16+ years
Languages Spoken:
English
See accepted insurances

Dr. Gross specializes in the diagnosis and treatment of nervous system disorders, which includes illnesses affecting the brain, spinal cord, muscles and nerves. Common conditions treated by a neurologist include stroke, epilepsy, chronic headaches, Parkinson's disease, dementia and multiple sclerosis. In addition, Dr. Gross offers expertise in Neuro-Ophthalmology, disorders originating in the nervous system that affect vision. Dr. Gross is rated as an Advanced provider by MediFind in the treatment of Limb-Girdle Muscular Dystrophy Type 2C. His top areas of expertise are Dementia, Stroke, Strabismus, and Seizures.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Brooks's expertise for a condition
ConditionClose
View All 13 Distinguished Conditions
View All 38 Advanced Conditions
View All 36 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile